ES541285A0 - SULFO-NAMIDAS BASED ANTI-HYPERTENSIVE PROCEDURE - Google Patents

SULFO-NAMIDAS BASED ANTI-HYPERTENSIVE PROCEDURE

Info

Publication number
ES541285A0
ES541285A0 ES541285A ES541285A ES541285A0 ES 541285 A0 ES541285 A0 ES 541285A0 ES 541285 A ES541285 A ES 541285A ES 541285 A ES541285 A ES 541285A ES 541285 A0 ES541285 A0 ES 541285A0
Authority
ES
Spain
Prior art keywords
namidas
hypertensive
sulfo
procedure
based anti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541285A
Other languages
Spanish (es)
Other versions
ES8602413A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pharmaceutical Corp
Original Assignee
USV Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pharmaceutical Corp filed Critical USV Pharmaceutical Corp
Publication of ES8602413A1 publication Critical patent/ES8602413A1/en
Publication of ES541285A0 publication Critical patent/ES541285A0/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)
ES541285A 1984-03-16 1985-03-15 SULFO-NAMIDAS BASED ANTI-HYPERTENSIVE PROCEDURE Granted ES541285A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59013484A 1984-03-16 1984-03-16

Publications (2)

Publication Number Publication Date
ES8602413A1 ES8602413A1 (en) 1985-12-16
ES541285A0 true ES541285A0 (en) 1985-12-16

Family

ID=24361002

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541285A Granted ES541285A0 (en) 1984-03-16 1985-03-15 SULFO-NAMIDAS BASED ANTI-HYPERTENSIVE PROCEDURE

Country Status (8)

Country Link
JP (1) JPS60209576A (en)
AU (1) AU3987185A (en)
DE (1) DE3508977A1 (en)
ES (1) ES541285A0 (en)
FR (1) FR2561243A1 (en)
GB (1) GB2155927A (en)
IT (1) IT1184162B (en)
ZA (1) ZA851884B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115448857A (en) * 2021-06-08 2022-12-09 联化科技（台州）有限公司 Method for continuously preparing sulfonamide compound

Also Published As

Publication number Publication date
FR2561243A1 (en) 1985-09-20
IT1184162B (en) 1987-10-22
GB8506420D0 (en) 1985-04-17
ES8602413A1 (en) 1985-12-16
GB2155927A (en) 1985-10-02
JPS60209576A (en) 1985-10-22
IT8519920A0 (en) 1985-03-15
DE3508977A1 (en) 1985-09-19
AU3987185A (en) 1985-09-19
ZA851884B (en) 1985-12-24

Similar Documents

Publication Publication Date Title
DK32285D0 (en) A DIESELAGGREAT
ATA89385A (en) WIRING
IT1191637B (en) ORGANOSYLOXANE-OXYLKYLENE COPOLYMERS
FR2577138B1 (en) L-CARNOSIN-BASED IMMUNO-REGULATOR
KR860001633A (en) A/D converter
FR2589698B1 (en) EXTENSION TABLE
IT1214659B (en) LINALOL-BASED PESTICIDE
DE3665304D1 (en) OBELMYCIN A
BR8506438A (en) PESTICIDE-RELATED IMPROVEMENTS
IT1183698B (en) SPIRO-CYCLIC ANTI-HYPERTENSIVE COMPOUNDS
ES541285A0 (en) SULFO-NAMIDAS BASED ANTI-HYPERTENSIVE PROCEDURE
DK558485A (en) TOOL
RO90437A2 (en) PROCEDURE FOR OBTAINING A POLYSHARIDE
DK309788A (en) Base course
ES287714Y (en) A VELOCIPED
IT1183699B (en) SPIRO-AMIDOAMMINE ANTI-HYPERTENSIVE COMPOUNDS
DK306688D0 (en) Base course
FR2570590B1 (en) TABLE SET
FR2602227B1 (en) NITROALKAN-BASED EXPLOSIVES
FR2586248B1 (en) INSECTICIDE BASED ON TRIHALOGENO-IMIDAZOLE
FR2566246B3 (en) CROSSED BASE TABLE
KR860004043U (en) Set for science practice
BR8502799A (en) HERBICIDIC COMPOSITIONS BASED ON DICLORO-QUINOLEIN DERIVATIVES
MX163870B (en) BIOCIDAL COMPOSITION BASED ON ISOTIAZOLONE
RO92464A2 (en) COMPOSITION BASED ON POLYETHYLENTEREPHTHALATE